Skip to main content
Top
Published in: BMC Gastroenterology 1/2010

Open Access 01-12-2010 | Research article

Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008

Authors: Edith MM Kuiper, Bettina E Hansen, Herold J Metselaar, Robert A de Man, Els B Haagsma, Bart van Hoek, Henk R van Buuren

Published in: BMC Gastroenterology | Issue 1/2010

Login to get access

Abstract

Background

A decrease in the need for liver transplantations (LTX) in Primary Biliary Cirrhosis (PBC), possibly related to treatment with ursodeoxycholic acid (UDCA), has been reported in the USA and UK. The aim of this study was to assess LTX requirements in PBC over the past 20 years in the Netherlands.

Methods

Analysis of PBC transplant data of the Dutch Organ Transplant Registry during the period 1988-2008, including both absolute and proportional numbers. The indication for LTX was categorized as liver failure, hepatocellular carcinoma or poor quality of life (severe fatigue or pruritus). Data were analysed for two decades: 1.1.1988-31.12.1997 (1st) and 1.1.1998-31.12.2007 (2nd). The severity of disease was quantified using MELD scores. To fit lines which show trends over time we applied a linear regression model.

Results

A total of 110 patients (87% women) was placed on the waiting list. 105 patients were transplanted (1st: 61, 2nd: 44), 5 (5%) died while listed. The absolute annual number of LTX for PBC slightly decreased during the 20 year period, the proportional number decreased significantly. At the time of LTX the mean age was 53.6 yrs. (1st: 53.4, 2nd: 53.8), the mean MELD score 13.9 (1st:14.5, 2nd:13.0). The median interval from diagnosis to LTX was 90.5 months (1st:86.5, 2nd: 93.5). 69% of patients was treated with UDCA (1st 38%, 2nd 82%).

Conclusions

Over the past 20 years the absolute number of LTX for PBC in the Netherlands showed a tendency to decrease whereas the proportional decrease was significant. There was a trend over time toward earlier transplantation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lee J, Belanger A, Doucette JT, Stanca C, Friedman S, Bach N: Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007, 5 (11): 1313-1315. 10.1016/j.cgh.2007.07.015.CrossRefPubMed Lee J, Belanger A, Doucette JT, Stanca C, Friedman S, Bach N: Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007, 5 (11): 1313-1315. 10.1016/j.cgh.2007.07.015.CrossRefPubMed
2.
go back to reference Liermann Garcia RF, Evangelista GC, McMaster P, Neuberger J: Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology. 2001, 33 (1): 22-27. 10.1053/jhep.2001.20894.CrossRefPubMed Liermann Garcia RF, Evangelista GC, McMaster P, Neuberger J: Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology. 2001, 33 (1): 22-27. 10.1053/jhep.2001.20894.CrossRefPubMed
3.
go back to reference Milkiewicz P: Liver transplantation in primary biliary cirrhosis. Clin Liver Dis. 2008, 12 (2): 461-472. 10.1016/j.cld.2008.02.015.CrossRefPubMed Milkiewicz P: Liver transplantation in primary biliary cirrhosis. Clin Liver Dis. 2008, 12 (2): 461-472. 10.1016/j.cld.2008.02.015.CrossRefPubMed
4.
go back to reference Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al: Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008, 48 (3): 871-877. 10.1002/hep.22428.CrossRefPubMed Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al: Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008, 48 (3): 871-877. 10.1002/hep.22428.CrossRefPubMed
5.
go back to reference Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, et al: Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009, 136 (4): 1281-1287. 10.1053/j.gastro.2009.01.003.CrossRefPubMed Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, et al: Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009, 136 (4): 1281-1287. 10.1053/j.gastro.2009.01.003.CrossRefPubMed
6.
go back to reference Pares A, Caballeria L, Rodes J: Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology. 2006, 130 (3): 715-720. 10.1053/j.gastro.2005.12.029.CrossRefPubMed Pares A, Caballeria L, Rodes J: Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology. 2006, 130 (3): 715-720. 10.1053/j.gastro.2005.12.029.CrossRefPubMed
7.
go back to reference Taal BG, Schalm SW, Ten Kate FW, Hermans J, Geertzen RG, Feltkamp BE: Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. Hepatogastroenterology. 1983, 30 (5): 178-182.PubMed Taal BG, Schalm SW, Ten Kate FW, Hermans J, Geertzen RG, Feltkamp BE: Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. Hepatogastroenterology. 1983, 30 (5): 178-182.PubMed
8.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al: A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33 (2): 464-470. 10.1053/jhep.2001.22172.CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al: A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33 (2): 464-470. 10.1053/jhep.2001.22172.CrossRefPubMed
9.
go back to reference Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000, 31 (4): 864-871. 10.1053/he.2000.5852.CrossRefPubMed Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000, 31 (4): 864-871. 10.1053/he.2000.5852.CrossRefPubMed
10.
go back to reference Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A: Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989, 10 (1): 1-7. 10.1002/hep.1840100102.CrossRefPubMed Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A: Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989, 10 (1): 1-7. 10.1002/hep.1840100102.CrossRefPubMed
11.
go back to reference James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV: Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology. 1999, 30 (2): 390-394. 10.1002/hep.510300213.CrossRefPubMed James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV: Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology. 1999, 30 (2): 390-394. 10.1002/hep.510300213.CrossRefPubMed
12.
go back to reference Lazaridis KN, Talwalkar JA: Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J Clin Gastroenterol. 2007, 41 (5): 494-500. 10.1097/01.mcg.0000225653.07932.8f.CrossRefPubMed Lazaridis KN, Talwalkar JA: Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J Clin Gastroenterol. 2007, 41 (5): 494-500. 10.1097/01.mcg.0000225653.07932.8f.CrossRefPubMed
Metadata
Title
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008
Authors
Edith MM Kuiper
Bettina E Hansen
Herold J Metselaar
Robert A de Man
Els B Haagsma
Bart van Hoek
Henk R van Buuren
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2010
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-10-144

Other articles of this Issue 1/2010

BMC Gastroenterology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine